Herein, their cytotoxicity was analyzed by alive/death confocal microscopy (CLSM) assays and, to verify that PTX pharmacological activity did not change upon loading to PDA NPs, NP ability to induce apoptosis in HER2+ cancer cells was verified by flow cytometry. The gene discussed is ERBB2; the disease is cancer.